Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.
Andrés Jiménez, Elvira G Jordà, Ester Verdaguer, David Pubill, Francesc X Sureda, Anna M Canudas, Elena Escubedo, Jordi Camarasa, Antoni Camins, Mercè Pallàs
Toxicology and Applied Pharmacology April 15, 2004 DOI: 10.1016/j.taap.2003.12.017 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | In vitro experimental study Peer reviewed |
|---|---|
| Population | Cultured cerebellar granule neurones (CGNs) |
| Interventions | Methamphetamine MDMA z.VAD.fmk MK-801 NBQX alpha-tocopherol |
| Dose | METH or MDMA 1-5 mM; z.VAD.fmk 100 microM; MK-801 10 microM; NBQX 10 microM; alpha-tocopherol 1-15 microM; 4 mM METH or MDMA for co-treatment |
| Duration | 24 h and 48 h treatment |
| Measures | cell viability, apoptosis by flow cytometry (hypodiploid population), nuclear chromatin condensation, cytochrome C release, caspase-3-like activation |
| Key findings | Methamphetamine and MDMA (1-5 mM) caused apoptotic death of cultured cerebellar granule neurons over 48 hours, an effect blocked by the caspase inhibitor z.VAD.fmk but not by the excitotoxicity blockers MK-801 or NBQX. Antioxidant treatment partially reversed toxicity, and the drugs induced cytochrome C release and caspase-3-like activation, leading the authors to propose caspase inhibitors as a possible protective strategy. |
Abstract
The neurotoxic action of the abuse drugs methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA) on cerebellar granule neurones (CGNs) culture was examined. Treatment for 48 h with METH or MDMA (1-5 mM) induced a higher decrease in viability than 24 h treatment. z.VAD.fmk (100 microM) but not MK-801 nor NBQX recovered control viability values. In both cases, cell death was characterised as apoptotic rather than necrotic by morphology cell observation. Apoptosis measured by flow cytometry indicated an increase in the hypodiploid population after 48 h treatment with METH and MDMA. Apoptosis was reverted by the presence of z.VAD.fmk (100 microM) but not by 10 microM MK-801 or NBQX. Similar results were obtained by analysing nuclear chromatine condensation. These results ruled out excitotoxic participation in amphetamine derivative-induced neurotoxicity in CGNs. Participation of radical oxygen species (ROS) was evaluated using alpha-tocopherol (1-15 microM) and cytometric studies. The co-treatment with 4 mM METH or MDMA for 48 h partially reverted neurotoxic action and apoptotic features, indicating ROS implication in CGNs death by amphetamine derivatives. Alteration of mitochondrial function induced cytochrome C (Cyt C) release after 48-h treatment with METH and MDMA (4 mM). There was also indication of caspase-3-like activation, measured by immunoanalysis and biochemically. Finally, neurodegenerative action caused by amphetamine derivatives may be prevented by using caspase inhibitors.
Citations in the library
Cited by 28
- A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research". Human Psychopharmacology: Clinical and Experimental March 1, 2014
- Neural Effects of MDMA as Determined by Functional Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Awake Marmoset Monkeys Annals of the New York Academy of Sciences August 1, 2006
- A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA) Current Research in Toxicology May 27, 2022
- Effects of 3,4-methylenedioxymethamphetamine administration on retinal physiology in the rat. PLoS One June 14, 2016
- Neuronal Nicotinic Receptors as New Targets for Amphetamine-Induced Oxidative Damage and Neurotoxicity Pharmaceuticals June 15, 2011
and 23 more in the library
Cites 10
- Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings The Lancet October 1, 1998
- (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies Neuropsychobiology 2000
- RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy") Science September 27, 2002
- Human Research on MDMA (3,4-Methylene- dioxymethamphetamine) Neurotoxicity: Cognitive and Behavioural Indices of Change Neuropsychobiology 2000
- Lasting Neuropsychiatric Sequelae of (??)Methylenedioxymethamphetamine (???Ecstasy???) in Recreational Users Journal of Clinical Psychopharmacology October 1, 1991
and 5 more in the library